{"pressItemDictionary": {"Press Releases": [{"Title": "Update On Local Covid-19 Situation (2 Dec 2021)", "PublishedDate": "/Date(1638458280000)/", "LastModifiedDateTimeList": null, "PublishedDateStr": "02 Dec 2021", "Summary": "", "MainContent": "<table border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"908\"> <tbody><tr> <td width=\"908\" valign=\"top\"> <p><strong>Summary of local situation </strong></p> <p>&nbsp;</p> <ul><li>991 cases remain warded in hospital. 194 cases require oxygen supplementation in the general ward, 9 are unstable and under close monitoring in the intensive care unit (ICU), and 60 are critically ill and intubated in the ICU. The current overall ICU utilisation rate is 56.4%. <p>&nbsp;</p></li><li>Over the last 28 days, of the 55,935 infected individuals, 98.7% had no or mild symptoms, 0.9% required oxygen supplementation in the general ward, 0.2% were in the ICU, and 0.2% has died. <p>&nbsp;</p></li><li>As of 1 December 2021, the total number of individuals who have completed their full regimen/received two doses of COVID-19 vaccines constitutes 96% of the eligible population, and 87% of the total population. As a percentage of total population, 87% has received at least one dose, and 27% has received their booster shots. <p>&nbsp;</p></li><li>Over the past day, 2,056 cases were discharged, of whom 332 are seniors aged 60 years and above. 1,101 new cases of COVID-19 infection were detected, with 1,050 in the community, 41 in the migrant worker dormitories and 10 imported cases. The weekly infection growth rate is 0.70. <p>&nbsp;</p></li><li>As announced earlier this evening, MOH has detected two imported COVID-19 cases who have tested preliminarily positive for the Omicron variant on 2 December. Both are fully vaccinated and experiencing mild symptoms. They were isolated upon arrival in Singapore on 1 December, and had not interacted in the community. There is currently no evidence of any community transmission from these cases. </li></ul> </td> </tr> </tbody></table><br><strong>Situation at Hospitals</strong><br><br>1. As of 2 December 2021, 194 cases require oxygen supplementation in the general ward, 9 are unstable and under close monitoring in the ICU to prevent further deterioration, and 60 are critically ill and intubated in the ICU. The current overall ICU utilisation rate is 56.4%.<br><br><strong><span style=\"text-decoration: underline;\">Figure 1:</span></strong> Daily Adult ICU Bed Utilisation<br><div><br></div><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure1_2dec2021.png?sfvrsn=2566743_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure1_2dec2021.png?sfvrsn=2566743_0\" data-displaymode=\"Original\" alt=\"Figure1_2dec2021\" title=\"Figure1_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br><br><strong>Status of Patients</strong><br><br>2. Over the last 28 days, 98.7% of local infected cases were asymptomatic or had mild symptoms, 0.9% required oxygen supplementation in the general ward, 0.1% were unstable and under close monitoring in the ICU to prevent further deterioration, and 0.1% had been critically ill and intubated in the ICU.&nbsp;<br><br><strong><span style=\"text-decoration: underline;\">Figure 2:</span></strong> Local Cases in the Last 28 Days by Severity of Condition<sup>1</sup>&nbsp; &nbsp;<br><div><br></div><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure2_2dec2021.png?sfvrsn=643a82eb_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure2_2dec2021.png?sfvrsn=643a82eb_0\" data-displaymode=\"Original\" alt=\"Figure2_2dec2021\" title=\"Figure2_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br>3. Seniors 60 years old and above, especially if unvaccinated, continue to be more adversely affected by COVID-19:&nbsp;<br><br><strong><span style=\"text-decoration: underline;\">Figure 3:</span></strong> Patients Needing Oxygen Supplementation, ICU Care or Died<sup>2</sup>, by Age Groups<br><div><br><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure3_2dec2021.png?sfvrsn=3d6d1b4a_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure3_2dec2021.png?sfvrsn=3d6d1b4a_0\" data-displaymode=\"Original\" alt=\"Figure3_2dec2021\" title=\"Figure3_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br><br></div><strong>Vaccination&nbsp;</strong><br><br>4. As of 1 December 2021, the total number of individuals who have completed their full regimen/ received two doses of COVID-19 vaccines constitutes 96% of the eligible population, and 87% of the total population.&nbsp; As a percentage of total population, 87% has received at least one dose, and 27% has received their booster shots.<br><br>5. Over the past 7 days, the number of fully vaccinated and non-fully vaccinated cases who are critically ill in the ICU are at 0.5 and 4.2 per 100,000 population respectively. Over the same period, the number of fully vaccinated and non-fully vaccinated cases who died are 0.1 and 0.5 per 100,000 population respectively. Among seniors aged 60 and above, the number of fully vaccinated and non-fully vaccinated cases who are critically ill in the ICU are 2.0 and 37.7 respectively.&nbsp; The number of fully vaccinated and non-fully vaccinated seniors who died are 0.3 and 4.8 respectively.&nbsp;<br><br><strong><span style=\"text-decoration: underline;\">Figure 4:</span></strong> 7-Day Moving Average of Number of Deaths and Active Cases in ICU, per 100,000 Population by Vaccination Status<sup>3&nbsp; </sup>&nbsp;<br><br><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure4_2dec2021.png?sfvrsn=8948084d_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure4_2dec2021.png?sfvrsn=8948084d_0\" data-displaymode=\"Original\" alt=\"Figure4_2dec2021\" title=\"Figure4_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br><div><strong>Inflow and Outflow of Cases</strong><br><br>6. Over the past day, 2,056 cases were discharged, of whom 332 are seniors aged 60 years and above.&nbsp;<br><br>7. As of 2 December 2021, 12pm, the Ministry of Health has detected a total of 1,101 new cases of COVID-19 infection, comprising 1,050 community cases, 41 dormitory resident cases and 10 imported cases. Amongst the community cases today are 155 seniors who are aged 60 years and above. The ratio of community cases for the past week over the week before is 0.70.<br><br>8. 9 more cases, aged between 56 and 99 years, have passed away from complications due to COVID-19 infection. All of them had various underlying medical conditions.&nbsp;<br><br>9. As announced earlier this evening, MOH has detected two imported COVID-19 cases who have tested preliminarily positive for the Omicron variant on 2 December. Both cases were isolated upon arrival in Singapore on 1 December, and had not interacted in the community. There is currently no evidence of any community transmission from these cases. The cases are currently recovering in isolation wards at the National Centre for Infectious Diseases (NCID). Both are fully vaccinated, and have mild symptoms of cough and scratchy throat.<br><br>10. Contact tracing is ongoing. All 19 other passengers who came in on the same flight have tested negative for COVID-19 infection.<br><br><strong><span style=\"text-decoration: underline;\">Figure 5:</span></strong> Number of Community Cases by Age<br><div><br><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure5_2dec2021.png?sfvrsn=abee4408_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure5_2dec2021.png?sfvrsn=abee4408_0\" data-displaymode=\"Original\" alt=\"Figure5_2dec2021\" title=\"Figure5_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br><br></div><strong><span style=\"text-decoration: underline;\">Figure 6:</span></strong> Week-on-week Infection Ratio<sup>4&nbsp;</sup><br></div><br><a href=\"/images/librariesprovider5/covid-19-chart-(pr)/figure6_2dec2021.png?sfvrsn=df2c9a4a_0\"><img src=\"/images/librariesprovider5/covid-19-chart-(pr)/figure6_2dec2021.png?sfvrsn=df2c9a4a_0\" data-displaymode=\"Original\" alt=\"Figure6_2dec2021\" title=\"Figure6_2dec2021\" data-openoriginalimageonclick=\"true\"></a><br><br>11. Please refer to MOH\u2019s daily Situation Report (<a href=\"https://covidsitrep.moh.gov.sg/\" title=\"\" class=\"\" target=\"\">www.moh.gov.sg/covid-19/situation-report</a>) for details.<br><br>[1]&nbsp;Includes only new cases reported in the past 28 days. Based on cases\u2019 worst-ever condition; deceased cases previously in ICU are counted under \u2018Deceased\u2019 and not under \u2018Ever Critically ill and Intubated in ICU\u2019.<br><br>[2]&nbsp;May differ from the deaths reported for the day as the latter includes those who have passed on earlier, but whose cause of death was investigated and confirmed only later, e.g. Coroner\u2019s cases.<br><br>[3]&nbsp;Non-fully vaccinated comprises persons who are partially vaccinated and completely unvaccinated.<br><br>[4] Ratio of community cases in the past week over the week before.<br>", "PressCategory": ["Press Releases", "Highlights"], "CustomDetailUrl": "", "UrlName": "update-on-local-covid-19-situation-(2-dec-2021)", "CurrentPageUrl": null, "CustomPressWidgetLocationUrl": null}, {"Title": "Two Imported Covid-19 Cases Tested Preliminarily Positive for Omicron Variant", "PublishedDate": "/Date(1638443700000)/", "LastModifiedDateTimeList": null, "PublishedDateStr": "02 Dec 2021", "Summary": "", "MainContent": "<p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-family: Arial; font-size: 16px;\">&nbsp; &nbsp; &nbsp; &nbsp;The Ministry of Health (MOH) has detected two imported COVID-19 cases who have tested preliminarily positive for the Omicron variant on 2 December. Both cases were isolated upon arrival in Singapore on 1 December, and had not interacted in the community. There is currently no evidence of any community transmission from these cases.</span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">2.&nbsp; &nbsp; &nbsp;The cases are currently recovering in isolation wards at the National Centre for Infectious Diseases (NCID). Both are fully vaccinated, and have mild symptoms of cough and scratchy throat.&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">3.&nbsp; &nbsp; &nbsp;Both cases arrived from Johannesburg on board SQ479 on 1 December.</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in 0in 0in 0.5in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"margin: 0in 0in 0in 40px; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">a. Case 271487 is a 44 year-old male Singapore Permanent Resident who arrived in Singapore from Mozambique, transiting through Johannesburg. His pre-departure test in Mozambique on 29 November was negative for COVID-19 infection.&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px 0px 0px 40px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"margin: 0in 0in 0in 40px; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">b. Case 271598 is a 41 year-old female Singaporean who arrived in Singapore from South Africa on 1 December. Her pre-departure test in Johannesburg on 29 November was negative for COVID-19 infection.</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">4.&nbsp; &nbsp; &nbsp;They had undergone a polymerase chain reaction (PCR) test upon arrival in Singapore, and were immediately conveyed to a Stay-Home Notice (SHN) dedicated facility to be isolated while awaiting their test results. Upon confirmation of COVID-19 infection, they were conveyed to NCID.</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">5.&nbsp; &nbsp; &nbsp;Their PCR test results have revealed the presence of S-gene Target Failure which may be associated with the Omicron variant. The National Public Health Laboratory is conducting whole genome sequencing to confirm the variant.</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\"><strong>Contact tracing is ongoing, close contacts to be tested and quarantined</strong></span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">6.&nbsp; &nbsp; &nbsp;Contact tracing is ongoing. All 19 other passengers who came in on the same flight have tested negative for COVID-19 infection. These individuals were all quarantined under SHN at designated facilities upon arrival and are subjected to a testing regime which includes an on-arrival PCR test and a SHN exit PCR test.</span></span></p><p class=\"m_3515960457528291757ThesisSentence\" style=\"margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\"><span style=\"color: windowtext;\">&nbsp;</span></span></span></p><p class=\"m_3515960457528291757ThesisSentence\" style=\"margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\"><span style=\"color: windowtext;\">7.&nbsp; &nbsp; &nbsp;</span><span style=\"color: windowtext;\">Other close contacts of these cases, if any, will be placed on 10-day quarantine at designated facilities and undergo PCR tests at the start and end of their quarantine. All patients suspected or confirmed to be infected with the Omicron variant will be conveyed to NCID for isolation and clinical management. Home recovery will not apply.</span></span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0in; font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; text-align: justify;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">8.&nbsp; &nbsp; &nbsp;It is important for everyone to continue to play their part and remain vigilant to mitigate the spread of COVID-19.</span></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif;\"><span style=\"font-size: 16px;\"><span style=\"font-family: Arial;\">&nbsp;</span></span></p><p class=\"m_3515960457528291757Default\" style=\"margin: 0in; font-size: 12pt; font-family: Arial, sans-serif;\"><span style=\"font-family: Arial;\"><strong><span style=\"color: windowtext;\">MINISTRY OF HEALTH</span></strong></span></p><p class=\"m_3515960457528291757Default\" style=\"margin: 0in; font-size: 12pt; font-family: Arial, sans-serif;\"><span style=\"font-family: Arial;\"><strong><span style=\"color: windowtext;\">2 DECEMBER 2021</span></strong></span></p><p style=\"color: rgb(34, 34, 34); margin: 0px; font-size: small; font-family: Arial, Helvetica, sans-serif;\"><span style=\"font-family: Arial; font-size: 16px;\">&nbsp;</span></p>", "PressCategory": ["Press Releases", "Highlights"], "CustomDetailUrl": "", "UrlName": "two-imported-covid-19-cases-tested-preliminarily-positive-for-omicron-variant", "CurrentPageUrl": null, "CustomPressWidgetLocationUrl": null}, {"Title": "Reminder to Complete Primary Series of  Sinovac-coronavac and Sinopharm Vaccines ", "PublishedDate": "/Date(1638428400000)/", "LastModifiedDateTimeList": null, "PublishedDateStr": "02 Dec 2021", "Summary": "", "MainContent": "<p style=\"text-align: justify;\"><span style=\"color: rgb(13, 13, 13); font-family: Arial; font-size: 16px;\">&nbsp; &nbsp; &nbsp;From 1 December 2021, the Ministry of Health has been progressively sending out SMS notifications to about 70,000 persons [1]&nbsp;</span><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">who have taken two doses of the&nbsp;Sinovac-CoronaVac or Sinopharm vaccines and are</span><span style=\"color: rgb(13, 13, 13); font-family: Arial; font-size: 16px;\">due for the remaining dose of their three-dose regime. These&nbsp;</span><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">persons are eligible</span><span style=\"color: rgb(13, 13, 13); font-family: Arial; font-size: 16px;\">&nbsp;for their third dose from three months after their second dose.<br><br>2. &nbsp;&nbsp;</span><span style=\"text-align: left; color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">To maintain their</span><span style=\"text-align: left; color: rgb(13, 13, 13); font-family: Arial; font-size: 16px;\">&nbsp;fully vaccinated status from 1 January 2022 onwards,</span><span style=\"text-align: left; color: rgb(13, 13, 13); font-family: Arial; font-size: 16px;\">they are strongly encouraged to take their third dose&nbsp;<strong>before 31 December 2021, as long as their second dose had been administered three months ago</strong>.&nbsp;</span><span style=\"text-align: left; font-family: Arial; font-size: 16px;\">Beyond this time interval, the&nbsp;individual\u2019s&nbsp;vaccination status will revert to&nbsp;\u2018additional dose needed\u2019&nbsp;and will be subject to the current&nbsp;Vaccination-Differentiated Safe Management Measures (VDS) [2],</span><span style=\"text-align: left; font-family: Arial; font-size: 16px;\">as well as the Workforce Vaccination Measures, both of which will take effect on&nbsp;<strong>1 January 2022</strong>. Individuals should bear in mind the following:</span></p><p style=\"text-align: justify;\"><p style=\"margin-left: 40px;\"><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">a)&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">Individuals who have already received two doses of Sinovac-CoronaVac or Sinopharm vaccines are&nbsp;<strong>strongly recommended to receive a PSAR-authorised mRNA vaccine for their third dose</strong>&nbsp;unless they are medically ineligible to do so. They can walk into&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">any vaccination centre offering the mRNA vaccines to receive their third dose.&nbsp;The list of vaccination centre offering mRNA vaccines can be found on&nbsp;</span><a href=\"https://www.vaccine.gov.sg/locations-vcs\" title=\"\" class=\"\" target=\"\"></a><a href=\"http://www.vaccine.gov.sg/locations\" style=\"font-family: Arial; font-size: 16px;\">www.vaccine.gov.sg/locations</a><u style=\"font-family: Arial; font-size: 16px;\"><span style=\"color: rgb(5, 99, 193);\">-vcs</span></u><span style=\"font-family: Arial; font-size: 16px;\">.&nbsp;</span></p></p><p style=\"margin-left: 40px; text-align: justify;\"><span style=\"font-family: Arial; font-size: 16px;\"><span style=\"font-family: Arial;\">b) Otherwise, t</span><span style=\"font-family: Arial;\">hey should&nbsp;<strong>complete their primary series with a third dose of the Sinovac-CoronaVac or Sinopharm vaccines</strong>, whichever was received for the first two doses. The Sinovac-CoronaVac vaccine can be taken at any of the PSAR-authorised private clinics.&nbsp;</span><span style=\"font-family: Arial;\">The list of PSAR-authorised private clinics can be found on&nbsp;</span><a href=\"https://www.vaccine.gov.sg/locations\" target=\"_blank\" title=\"\" class=\"\">www.vaccine.gov.sg/locations</a>.&nbsp;</span></p><p style=\"text-align: justify;\"><span style=\"font-family: Arial; font-size: 16px;\">3. &nbsp; Persons who developed an allergic reaction to the first dose of the mRNA vaccine and received the Sinovac-CoronaVac vaccine for their second dose should also complete a third dose of Sinovac-CoronaVac vaccine, 28 days after their second dose, to maintain their vaccination status.</span><p><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\"><br>4. &nbsp;&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">The three-dose requirement applies to individuals who have had one dose of the Sinovac-CoronaVac or Sinopharm vaccines, as part of a two-dose&nbsp;combination of different World Health Organization\u2019s Emergency Use Listing (WHO-EUL) vaccine brands [3]. Further details on the requirements for persons&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">who have received a mixed vaccine combination incorporating Sinovac-CoronaVac or Sinopharm vaccines, as well as recovered persons who took these vaccines, can be found on&nbsp;</span><a href=\"https://go.gov.sg/sinovac-mixed-vac-combi.\" title=\"\" class=\"\" target=\"\"></a><a href=\"https://go.gov.sg/sinovac-mixed-vac-combi\" style=\"font-family: Arial; font-size: 16px;\">https://go.gov.sg/sinovac-mixed-vac-combi</a><span style=\"font-family: Arial; font-size: 16px;\">.</span></p></p><p style=\"text-align: justify;\"><p><span style=\"font-family: Arial; font-size: 16px;\"></span><strong style=\"font-family: Arial; font-size: 16px;\">Grace Period for Children Turning 13 in 2022 to Get Fully Vaccinated&nbsp;<br><br></strong><span style=\"font-family: Arial; font-size: 16px;\">5. </span><strong style=\"font-family: Arial; font-size: 16px;\">&nbsp;&nbsp;</strong><span style=\"font-family: Arial; font-size: 16px;\">As announced on 20 November 2021, the concession for unvaccinated individuals to perform a pre-event test (PET)</span><span style=\"font-family: Arial; font-size: 16px;\">&nbsp;in lieu of being fully vaccinated will be removed with effect on&nbsp;</span><strong style=\"font-family: Arial; font-size: 16px;\">1 January 2022</strong><span style=\"font-family: Arial; font-size: 16px;\">. Hence, only fully vaccinated, recovered, or medically ineligible individuals, or children aged 12 years and below (i.e. those born in 2010 or after), will be allowed to enter settings and participate in activities where VDS are implemented [4]</span><span style=\"font-family: Arial; font-size: 16px;\">.&nbsp;<br><br>6. &nbsp;&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">A grace period will be extended to children born in December 2009 to allow them sufficient time to get fully vaccinated. Children born in 2009 who will turn 13 in 2022 will need to be fully vaccinated to enter venues and participate in activities with VDS from&nbsp;</span><strong style=\"font-family: Arial; font-size: 16px;\">1 March 2022&nbsp;</strong><span style=\"font-family: Arial; font-size: 16px;\">(instead of 1 January 2022).<br><br></span><strong style=\"font-family: Arial; font-size: 16px;\"><span style=\"color: rgb(51, 51, 51);\">Workforce Vaccination Measures</span></strong></p></p><p style=\"text-align: justify;\"><p><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">7. &nbsp;&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">With the implementation of the Workforce Vaccination Measures from 1 January 2022, we will also phase out the \u201cVaccinate or Regular Test\u201d regime for all sectors that were onboard the regime as of the same date.&nbsp;</span></p></p><p style=\"text-align: justify;\"><p><span style=\"color: rgb(51, 51, 51); font-family: Arial; font-size: 16px;\">8. &nbsp;&nbsp;</span><span style=\"font-family: Arial; font-size: 16px;\">We continue to strongly recommend persons who can take the PSAR-authorised mRNA vaccines to do so given its higher vaccine effectiveness against infection and severe disease. &nbsp;&nbsp;<br></span></p></p><p style=\"text-align: justify;\"><span style=\"font-family: Arial; font-size: 16px;\"></span><span class=\"normaltextrun\" style=\"text-align: left; font-family: Arial; font-size: 16px;\"><strong>MINISTRY OF HEALTH</strong></span><span class=\"eop\" style=\"text-align: left; font-family: Arial; font-size: 16px;\"><br></span><span class=\"normaltextrun\" style=\"text-align: left; font-family: Arial; font-size: 16px;\"><strong>3 DECEMBER&nbsp;2021</strong></span><span class=\"eop\" style=\"text-align: left; font-family: Arial; font-size: 16px;\">&nbsp;&nbsp;<br></span></p><div><table border=\"0\" cellspacing=\"0\" cellpadding=\"0\"><tbody><tr><td width=\"1055\" valign=\"top\"><p style=\"text-align: justify;\"><span style=\"font-family: Arial; font-size: 16px;\"><u>Note</u>: Paragraph 2 has been updated on 3 December 2021</span></p><p style=\"text-align: justify;\"><span style=\"font-family: Arial;\"><span style=\"font-size: 16px;\">2. To maintain their fully vaccinated status from 1 January 2022 onwards, they are strongly encouraged to take their third dose&nbsp;<strong>before 31 December 2021, as long as their second dose had been administered three months ago</strong>. Beyond this time interval, the individual\u2019s vaccination status will&nbsp;revert to \u2018additional dose needed\u2019 and&nbsp;will be subject to the current Vaccination-Differentiated Safe Management Measures (VDS), as well as the Workforce Vaccination Measures, both of which will take effect on&nbsp;<strong>1 January 2022</strong>. Individuals should bear in mind the following:&nbsp;</span></span></p></td></tr></tbody></table><p>&nbsp;</p><hr align=\"left\" size=\"1\" width=\"33%\"><div id=\"ftn1\"><p><span style=\"font-family: Arial; font-size: 13px;\">[1] As of 30 November 2021.&nbsp;</span></p></div><div id=\"ftn2\"><p><span style=\"font-family: Arial; font-size: 13px;\">[2] https://www.mom.gov.sg/newsroom/press-releases/2021/1023-implementation-of-workforce-vaccination-measures</span></p></div><div id=\"ftn3\"><p><span style=\"font-family: Arial; font-size: 13px;\">[3] Excluding the Johnson &amp; Johnson/ Janssen single-dose COVID-19 vaccine.</span></p></div><div id=\"ftn4\"><p><span style=\"font-family: Arial; font-size: 13px;\">[4] Subject to venue and/or event-specific capacities.</span></p></div></div>", "PressCategory": ["Highlights", "Press Releases"], "CustomDetailUrl": "", "UrlName": "reminder-to-complete-primary-series-of-sinovac-coronavac-and-sinopharm-vaccines_2Dec2021", "CurrentPageUrl": null, "CustomPressWidgetLocationUrl": null}]}, "pressItemDictionaryCount": 1, "allowPagination": true, "selectedCategoryForPagination": "Press Releases", "sectionsListingOrder": ["Press Releases"], "paginationInfoDictionary": {"Press Releases": {"ItemsPerPage": 10, "CurrentPageIndex": 0, "LastPageIndex": 0}}}